Pregled bibliografske jedinice broj: 857411
Analytical verification and quality assessment of the Tosoh HLC-723GX HbA1c analyzer
Analytical verification and quality assessment of the Tosoh HLC-723GX HbA1c analyzer // Practical laboratory medicine, 7 (2017), 15-18 doi:10.1016/j.plabm.2016.12.001 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 857411 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Analytical verification and quality assessment of the Tosoh HLC-723GX HbA1c analyzer
Autori
Ris, Marko ; Božičević, Sandra ; Radišić Biljak, Vanja ; Vučić Lovrenčić, Marijana
Izvornik
Practical laboratory medicine (2352-5517) 7
(2017);
15-18
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
HbA1c ; Quality targets ; Six sigma ; Tosoh HLC-723GX analyzer
Sažetak
Objectives: Ion-exchange high-performance liquid chromatography (IE-HPLC) has long been used as a reproducible and versatile analytical tool for HbA1c measurement. In this study, we performed analytical verification and quality assessment of the recently introduced small IE-HPLC Tosoh HLC- 723GX HbA1c analyzer, and a comparison of results to immunoassay (IA) and capillary electrophoresis (CE). Design and methods: The total imprecision of Tosoh HLC-723GX was verified according to CLSI EP15-A2 protocol using commercial control materials (C-QC) and pooled human whole blood samples (HWB). The Sigma metric was used for the evaluation of quality targets. HbA1c results were compared to automated CE (MiniCap Flex Piercing, Sebia, France) and IA (Tinaquant HbA1c Gen 2, Cobas Integra 400+, Roche Diagnostics, USA) procedures. Results: The total imprecision of Tosoh HLC- 723GX-HbA1c for IFCC(mmol/mol) and NGSP(%) units was: 1.91/1.25% (HbA1c=31 mmol/mol/5.0%) and 0.51/0.63% (HbA1c=84 mmol/mol/ 9.8%) for C-QC, and 0.39/0.2% (HbA1c=47 mmol/mol/6.5%) and 0.77/0.46% (HbA1c=94 mmol/mol/10.8%) in HWB samples, respectively. Bland-Altman analysis did not reveal any deviation of the results between Tosoh HLC-723GX and CE: mean difference 0.0% (95%CI: −0.02927 to 0.02653%), while the mean HbA1c difference against IA was −0.07% (95% CI: −0.1039 to −0.02765). At the selected HbA1c clinical decision level (48 mmol/mol/6, 5%), six sigma analysis gave σ value of 3.91, within a desirable classification of performance. Conclusion: The analytical performance of the Tosoh HLC-723GX complies with the rigorous quality criteria for clinical use of HbA1c, with the results comparable to the CE procedure. Tosoh HLC-723GX provides a plausible analytical choice for reliable HbA1c measurement in lowvolume laboratories
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinička bolnica "Merkur",
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac
Poveznice na cjeloviti tekst rada:
Pristup cjelovitom tekstu rada doi
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus